FeesSafety
Pluang+

Velo3D inks 5-year research deal with Sandia Labs to advance metal 3D printing for defense and energy sectors

Market News
03 Nov 2026, 16:00 WIB
PRNewsWire
View Source
Bullish
Velo3D inks 5-year research deal with Sandia Labs to advance metal 3D printing for defense and energy sectors

Velo3D has signed a five-year Cooperative Research and Development Agreement (CRADA) with Sandia National Laboratories to collaborate on metal additive manufacturing research. This partnership aims to improve part reliability, repeatability, materials development, and workforce training, focusing on applications in defense and energy infrastructure. The agreement sets a framework for multiple projects, with each scoped separately. Velo3D plans to share findings as the research progresses, potentially advancing production-scale 3D printing technology.

Velo3D's new collaboration with Sandia National Laboratories provides context for technology sector activity on Pluang as of Nov 03, 2026 19:43 WIB. Among 150 priced US tech stocks, 73 rose and 76 fell. Notably, KLA Corp. gained 3.79% with 77% sell orders, contrasting with Palantir Technologies and Apple, which declined 5.91% and 4.02% respectively, both seeing a slight majority of sell orders and typical hold times ranging from 80 to 145 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App